We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$10.2B
AUM Growth
+$1.56B
(+18%)
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
13.92%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
794
New
107
Increased
295
Reduced
208
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$373M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$292M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$116M |
| 4 |
Estee Lauder
EL
|
+$83M |
| 5 |
Verisk Analytics
VRSK
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regal Rexnord
RRX
|
+$115M |
| 2 |
Intel
INTC
|
+$65.3M |
| 3 |
Cisco
CSCO
|
+$58.2M |
| 4 |
Ulta Beauty
ULTA
|
+$25M |
| 5 |
JPMorgan Chase
JPM
|
+$20.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Healthcare | 14.82% |
| 3 | Financials | 11.71% |
| 4 | Communication Services | 9.21% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares Russell 1000 Growth ETF
IWF
$127B
| $555K | 0.01% |
9,740
| – | – |
|
377
Bionano Genomics
BNGO
$13.3M
| $552K | 0.01% |
1,417
+167
| +13% | +$64.7K |
|
378
Alamos Gold
AGI
$13.9B
| $551K | 0.01% |
+62,522
| New | +$630K |
|
|
CTXS
379
DELISTED
Citrix Systems Inc
CTXS
| $547K | 0.01% |
3,973
-15,637
| -80% | -$2.23M |
|
380
Tetra Tech
TTEK
$8.97B
| $540K | 0.01% |
28,250
| – | – |
|
|
SPLK
381
DELISTED
Splunk Inc
SPLK
| $522K | 0.01% |
2,775
-77
| -3% | -$15.3K |
|
382
Otis Worldwide
OTIS
$27.7B
| $515K | 0.01% |
+8,248
| New | +$504K |
|
383
Archer Daniels Midland
ADM
$38.8B
| $512K | 0.01% |
11,013
-30
| -0.3% | -$1.31K |
|
384
IDEX
IEX
$17.2B
| $511K | 0.01% |
2,800
| – | – |
|
385
Canadian National Railway
CNI
$75.7B
| $502K | ﹤0.01% |
4,720
| – | – |
|
386
Tandem Diabetes Care
TNDM
$1.59B
| $499K | ﹤0.01% |
4,400
| – | – |
|
|
MRTX
387
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $498K | ﹤0.01% |
3,000
| – | – |
|
388
Cognizant
CTSH
$26.3B
| $495K | ﹤0.01% |
7,137
-2,496
| -26% | -$162K |
|
389
Tractor Supply
TSCO
$18B
| $492K | ﹤0.01% |
17,145
+1,735
| +11% | +$49.9K |
|
390
Carrier Global
CARR
$52.3B
| $485K | ﹤0.01% |
+15,889
| New | +$450K |
|
391
Eli Lilly
LLY
$1.1T
| $484K | ﹤0.01% |
3,268
+942
| +40% | +$146K |
|
392
Inovio Pharmaceuticals
INO
$76.1M
| $475K | ﹤0.01% |
3,410
+751
| +28% | +$157K |
|
393
Teladoc Health
TDOC
$1.29B
| $462K | ﹤0.01% |
+2,370
| New | +$502K |
|
394
iShares Currency Hedged MSCI Japan ETF
HEWJ
$750M
| $461K | ﹤0.01% |
14,423
+6,519
| +82% | +$203K |
|
395
iShares US Home Construction ETF
ITB
$2.35B
| $453K | ﹤0.01% |
+8,000
| New | +$418K |
|
396
Albemarle
ALB
$15.5B
| $449K | ﹤0.01% |
5,033
-433
| -8% | -$38.4K |
|
397
Kinross Gold
KGC
$32.5B
| $445K | ﹤0.01% |
+50,450
| New | +$436K |
|
398
Arcus Biosciences
RCUS
$3.66B
| $445K | ﹤0.01% |
25,949
+6,699
| +35% | +$150K |
|
399
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
| $445K | ﹤0.01% |
+6,056
| New | +$429K |
|
400
iShares US Industrials ETF
IYJ
$1.94B
| $441K | ﹤0.01% |
+5,280
| New | +$429K |
|
Similar funds
Bank Julius Baer & Co's Q3 2020 Portfolio in Review
As of Q3 2020, Bank Julius Baer & Co held 794 positions worth $10.2B, up 18% from $8.68B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Bank Julius Baer & Co deployed $1.43B of net new capital in Q3 2020, opening 107 new positions and adding to 295 existing holdings. Its largest new stake was Verisk Analytics: 449,765 shares worth $83.3M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Regal Rexnord, an estimated $115M trimmed.
- Bank Julius Baer & Co's largest Q3 2020 buy was Verisk Analytics: 449,765 shares worth $83.3M.
- Bank Julius Baer & Co added most to Apple in Q3 2020, an estimated $373M increase.
- Bank Julius Baer & Co's biggest Q3 2020 reduction was Regal Rexnord, cutting an estimated $115M.
- Bank Julius Baer & Co fully exited Ionis Pharmaceuticals in Q3 2020, selling an estimated $11.5M.
- Bank Julius Baer & Co's ten largest holdings make up 37% of its $10.2B portfolio in Q3 2020.
- Bank Julius Baer & Co opened 107 new positions and closed 60 in Q3 2020.
- Bank Julius Baer & Co's portfolio value rose 18% quarter-over-quarter to $10.2B.
Based on Bank Julius Baer & Co's 13F filing for Q3 2020, filed 10 Nov 2020.